NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.390
-0.040 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
2.580
+0.190 (7.95%)
After-hours: Apr 28, 2026, 7:59 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $276.40 million as of April 28, 2026. Its market cap has increased by 403.02% in one year.
Market Cap
276.40M
Enterprise Value
68.05M
1-Year Change
403.02%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $276.40M, an increase of 100.22%. That is a compound annual growth rate of 11.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 295.68M |
| Coherus Oncology | 283.76M |
| Editas Medicine | 282.85M |
| Minerva Neurosciences | 281.90M |
| AC Immune | 281.73M |
| C4 Therapeutics | 276.15M |
| Compugen | 276.10M |
| Cybin | 270.19M |